Xinsheng Li

Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP).

Qifu Li, H. Tian, Wei Jia, 2021, Science Bulletin.

Research on the Role of Th17Treg Cells and Their Factors in Graves' Disease with Different Iodine Nutritional Status

Cui-mei Wang, Z. Mu, Zhenjiang Hou, 2021 .

Research on the Mechanism of T Cell Subsets and Cytokines in Hashimoto's Thyroiditis

Z. Mu, Zhenjiang Hou, Xinsheng Li, 2020 .

Retrospective analysis of the relationship between elevated plasma levels of TXNIP and carotid intima-media thickness in subjects with impaired glucose tolerance and early Type 2 diabetes mellitus.

Xinsheng Li, Yongcai Zhao, Shiling Tang, 2015, Diabetes research and clinical practice.

Chemerin/CMKLR1 Axis Promotes the Progression of Proliferative Diabetic Retinopathy

Lihui Wang, A. Chang, Chonggui Zhu, 2021, International journal of endocrinology.

Relationship between thioredoxin-interacting protein (TXNIP) and islet β-cell dysfunction in patients with impaired glucose tolerance and hypertriglyceridemia.

Jun Zhu, Yong-cai Zhao, G. Song, 2015, International journal of clinical and experimental medicine.